These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs. Kuromaru O; Sakai K Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042 [TBL] [Abstract][Full Text] [Related]
10. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs. Hirata Y; Aisaka K J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of nitrovasodilators, K(+)-channel openers, and nicorandil on large and small coronary arteries in conscious dogs. Berdeaux A; Drieu la Rochelle C; Richard V; Giudicelli JF J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S17-21. PubMed ID: 1282171 [TBL] [Abstract][Full Text] [Related]
13. Hypotensive effects and biotransformation of nicorandil, a new antianginal agent, administered to rats by different routes: comparison with nitroglycerin and isosorbide dinitrate. Sakai K; Akima M; Hinohara Y; Obatake N J Pharm Pharmacol; 1984 Mar; 36(3):175-81. PubMed ID: 6144752 [TBL] [Abstract][Full Text] [Related]
14. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig. Jinno Y; Kasai H; Ohta H; Nishikori K; Fukushima H; Ogawa N Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium. Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748 [TBL] [Abstract][Full Text] [Related]
16. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery. Abe S; Nishimura J; Nakamura M; Kanaide H J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988 [TBL] [Abstract][Full Text] [Related]
17. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114 [TBL] [Abstract][Full Text] [Related]
18. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. Borg C; Mondot S; Mestre M; Cavero I J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil. Holzmann S; Kukovetz WR; Braida C; Pöch G Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362 [TBL] [Abstract][Full Text] [Related]
20. Cyclic GMP in nicorandil-induced vasodilatation and tolerance development. Kukovetz WR; Holzmann S J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S25-30. PubMed ID: 2447421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]